Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
DexCom
DXCM
5
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
US Stock MarketDetailed Quotes
PDSB PDS Biotechnology
- 0.9633
- -0.0367-3.67%
Close Apr 10 16:00 ET
- 0.9699
- +0.0066+0.69%
Pre 08:12 ET
43.73MMarket Cap-0.94P/E (TTM)
0.9860High0.9095Low168.68KVolume0.9700Open1.0000Pre Close159.87KTurnover0.38%Turnover RatioLossP/E (Static)45.40MShares4.420052wk High2.30P/B42.37MFloat Cap0.850552wk Low--Dividend TTM43.98MShs Float17.8500Historical High--Div YieldTTM7.65%Amplitude0.6153Historical Low0.9470Avg Price1Lot Size
About PDS Biotechnology Company
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
Company Profile
SymbolPDSB
Company NamePDS Biotechnology
Listing DateOct 1, 2015
Issue Price11.00
Founded2005
CEODr. Frank Bedu-Addo, PhD
MarketNASDAQ
Employees24
Fiscal Year Ends12-31
Address303A College Road East
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-800-208-3343
Websitehttp://www.pdsbiotech.com
Company Executives
- Name
- Position
- Salary
- Dr. Frank Bedu-Addo, PhD
- Director, President and Chief Executive Officer
- 5.01M
- Stephan F. Toutain, M.B.A.,M.S.
- Chief Operations Officer
- --
- Spencer D. Brown
- Senior Vice President, General Counsel and Chief Compliance Officer
- --
- Lars Boesgaard
- Chief Financial Officer and Principal Accounting Officer
- --
- Gregory L. Conn
- Chief Scientific Officer
- 1.68M
- Dr. Kirk V. Shepard, M.D.
- Chief Medical Officer
- --
- Stephen C. Glover
- Chairman of the Board
- 135.99K
- Dr. Ilian Petkov Iliev
- Director
- 82.99K
- Sir Richard Brook Sykes
- Independent Director
- 94.49K
- Kamil Ali-Jackson, Esq.
- Independent Director
- 106.49K
- Gregory G. Freitag, C.P.A.,J.D.
- Independent Director
- 105.49K
- Dr. Otis W. Brawley,M.D.
- Independent Director
- 82.99K
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now